How real estate can accelerate productivity as life sciences companies prioritize COVID-19 therapeutics, vaccines, and new diagnostics R&D amidst new guidelines.
Roger Humphrey
Advertisement
Roger Humphrey is executive managing director of JLL Life Sciences.
Articles by Roger Humphrey
Aging populations and increased access to healthcare translates into opportunities for biopharmaceutical companies.
Advertisement
Latest Updated Articles
- Labs on the Frontlines: Balancing Re-Entry and the Race to a COVID-19 Cure
Published: August 31st 2020 | Updated:
Emerging Life-Sciences Markets: New Partnerships, New CompetitorsPublished: February 1st 2016 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The Key Trends Driving Supply Chain Localization and Data Scrutiny in Biopharma
2
Excipient Innovation, Safer Solvents, and Supply Chain Resilience
3
The Bio/pharma Industry Navigates AI’s Impact on Workforce and Hiring
4
Turning Real-World Data into Actionable Drug Development Insights With AI
5
